Literature DB >> 12126636

Endothelial cell binding by systemic lupus antibodies: functional properties and relationship with anti-DNA activity.

Stefania Moscato1, Federico Pratesi, Francesca Bongiorni, Maria C Scavuzzo, Daniele Chimenti, Stefano Bombardieri, Paola Migliorini.   

Abstract

Anti-DNA antibodies and anti-endothelial cell antibodies (AECA) are often detected in systemic lupus erythematosus (SLE). Anti-DNA antibodies can also bind the membrane of human umbilical vein endothelial cells (HUVEC), but little is known about the presence of AECA in the population of immunoglobulins from SLE sera that do not bind DNA. The aim of this study is to analyse the ability of anti-DNA and non-anti-DNA antibodies from SLE sera to bind endothelial cell antigens and to investigate their pathogenic potential. Both anti-DNA and non-anti-DNA antibodies display AECA activity by immunoprecipitation and flow cytometry and in some patients recognize antigens of identical molecular weight. Complement-dependent cytotoxicity on HUVEC was not detected with either anti-DNA or non-anti-DNA antibodies. Similarly, apoptosis was not induced in HUVEC and HL60 incubated with anti-DNA or non-anti-DNA antibodies, as shown by the DNA hypodiploid content. These data indicate that AECA are highly heterogeneous, as they recognize a wide variety of surface molecules on HUVEC and equally present in anti-DNA and non-anti-DNA antibodies from SLE patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126636     DOI: 10.1006/jaut.2002.0583

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  8 in total

1.  Von Willebrand factor, red cell fragmentation, and disease activity in systemic lupus erythematosus.

Authors:  Rodolfo V Curiel; Rajkumari Bhagati; Lakshmi Basavaraju; Delona Norton; James Katz; Elizabeth Haile; Arthur Weinstein
Journal:  HSS J       Date:  2008-07-01

2.  Screening of a HUAEC cDNA library identifies actin as a candidate autoantigen associated with carotid atherosclerosis.

Authors:  P Margutti; F Delunardo; M Sorice; G Valesini; C Alessandri; R Capoano; E Profumo; A Siracusano; B Salvati; R Riganò; E Ortona
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 3.  Neutrophil extracellular chromatin traps connect innate immune response to autoimmunity.

Authors:  Marko Radic; Tony N Marion
Journal:  Semin Immunopathol       Date:  2013-04-18       Impact factor: 9.623

4.  Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations.

Authors:  Paola Margutti; Maurizio Sorice; Fabrizio Conti; Federica Delunardo; Mauro Racaniello; Cristiano Alessandri; Alessandra Siracusano; Rachele Riganò; Elisabetta Profumo; Guido Valesini; Elena Ortona
Journal:  Arthritis Res Ther       Date:  2005-05-20       Impact factor: 5.156

5.  Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies.

Authors:  Fabrizio Conti; Cristiano Alessandri; Daniela Bompane; Michele Bombardieri; Francesca Romana Spinelli; Anna Carlotta Rusconi; Guido Valesini
Journal:  Arthritis Res Ther       Date:  2004-06-17       Impact factor: 5.156

Review 6.  Endothelial Alterations in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Potential Effect of Monocyte Interaction.

Authors:  Laura Atehortúa; Mauricio Rojas; Gloria M Vásquez; Diana Castaño
Journal:  Mediators Inflamm       Date:  2017-05-04       Impact factor: 4.711

Review 7.  Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance.

Authors:  Cristiano Alessandri; Michele Bombardieri; Guido Valesini
Journal:  Adv Clin Chem       Date:  2006       Impact factor: 5.394

Review 8.  Cadherin Signaling in Cancer and Autoimmune Diseases.

Authors:  Margherita Sisto; Domenico Ribatti; Sabrina Lisi
Journal:  Int J Mol Sci       Date:  2021-12-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.